Discovery of Functional Antibody Drugs for GPCRs

Time: 9:00 am
day: Day One


  • Functional GPCR antibodies, such as agonist and modulator antibodies, tap the hidden therapeutic potential of the body’s biological activities
  • Abalone Bio’s Functional Antibody Selection Technology (FAST) platform couples a massively parallel in vivo search with data-powered selection to discover these ultra-rare antibodies
  • Using the FAST platform, we have identified a highly specific CB2 agonist antibody that has shown efficacy in in vivo models